Bone marrow stromal cell transplantation combined with angiotensin-converting enzyme inhibitor treatment in rat with acute myocardial infarction and the role of insulin-like growth factor-1

References

• Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, . Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919–26.
   PubMed Web of Science ®Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93–8.
   PubMed Web of Science ®Google Scholar
• Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V, . Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006;290:H2196–203.
   PubMed Web of Science ®Google Scholar
• Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, . Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005;115:326–38.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, . Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005;112:1128–35.
   PubMed Web of Science ®Google Scholar
• Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in a rat model of myocardial infarction. Ann Thorac Surg. 2005;80:229–37.
   PubMed Web of Science ®Google Scholar
• Huang YL, Qiu RF, Mai WY, Kuang J, Cai XY, Dong YG . Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro. J Zhejiang Univ Sci B. 2012;13(1):20–28 doi:10.1631/jzus.B1100117.
   PubMedGoogle Scholar
• Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, . Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326–42.
   Google Scholar
• Leri A, Liu Y, Wang X, Kajstura J, Malhotra A, Meggs LG, Anversa P. Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res. 1999;84:752–62.
   PubMedGoogle Scholar
• Dean RG, Bach LA, Burrell LM. Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling. J Histochem Cytochem. 2003;51:831–9.
   PubMed Web of Science ®Google Scholar
• Hu X, Wang J, Chen J, Luo R, He A, Xie X, Li J. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur J Cardiothorac Surg. 2007;31:438–43.
   PubMed Web of Science ®Google Scholar
• Reiss K, Cheng W, Pierzchalski P, Kodali S, Li B, Wang S, . Insulin-like growth factor-1 receptor and its ligand regulate the re-entry of adult ventricular myocytes into the cell cycle. Exp Cell Res. 1997;235:198–209.
   Google Scholar
• Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, Mosca JD. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci. 2003;10:228–41.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004, 95:9–20.
   PubMed Web of Science ®Google Scholar
• Jain M, Pfister O, Hajjar RJ, Liao R. Mesenchymal stem cells in the infarcted heart. Coron Artery Dis. 2005;16:93–7.
   PubMed Web of Science ®Google Scholar
• Guo J, Lin GS, Bao CY, Hu ZM, Hu MY. Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation. 2007;30:97–104.
   PubMed Web of Science ®Google Scholar
• Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 1995;92:8031–5.
   PubMed Web of Science ®Google Scholar
• Muguruma Y, Reyes M, Nakamura Y, Sato T, Matsuzawa H, Miyatake H, . In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. Exp Hematol. 2003;31:1323–30.
   Google Scholar
• Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem. 2000;275:10761–6.
   PubMed Web of Science ®Google Scholar
• Olivares EL, Costa-E-Sousa RH, Werneck-de-Castro JP, Pinho-Ribeiro V, Silva MG, Ribeiro KC, . Cellular cardiomyoplasty in large myocardial infarction: can the beneficial effect be enhanced by ACE-inhibitor therapy. Eur J Heart Fail. 2007;9:558–67.
   Google Scholar
• Li H, Yu B, Zhang Y, Pan Z, Xu W, Li H. Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem Biophys Res Commun. 2006;341: 320–5.
   PubMedGoogle Scholar
• Jiang S, Kh HH, Ahmed RP, Idris NM, Salim A, Ashraf M. Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J Mol Cell Cardiol. 2008;44: 582–96.
   PubMedGoogle Scholar
• Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, . Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 2003;25:968–73.
   Google Scholar
• Yau TM, Kim C, Li G, Zhang Y, Weisel RD, Li RK. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation. 2005;112(Suppl 9):I123–8.
   Google Scholar